Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension | 4 | 2008 | 823 | 0.300 |
Why?
|
| Peer Review, Research | 1 | 2018 | 15 | 0.300 |
Why?
|
| Research Support as Topic | 1 | 2018 | 89 | 0.290 |
Why?
|
| Research Personnel | 1 | 2018 | 191 | 0.260 |
Why?
|
| C-Reactive Protein | 1 | 2017 | 164 | 0.250 |
Why?
|
| Registries | 3 | 2019 | 431 | 0.230 |
Why?
|
| Education, Medical | 1 | 2005 | 117 | 0.200 |
Why?
|
| Databases, Genetic | 1 | 2013 | 103 | 0.200 |
Why?
|
| Intra-Abdominal Fat | 1 | 2012 | 45 | 0.180 |
Why?
|
| Killer Cells, Natural | 1 | 2012 | 99 | 0.170 |
Why?
|
| Lymphocyte Activation | 1 | 2012 | 244 | 0.170 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2011 | 33 | 0.170 |
Why?
|
| Computational Biology | 1 | 2013 | 324 | 0.170 |
Why?
|
| Antihypertensive Agents | 2 | 2008 | 285 | 0.170 |
Why?
|
| Self Care | 1 | 2011 | 173 | 0.150 |
Why?
|
| Internet | 1 | 2011 | 234 | 0.150 |
Why?
|
| Vulnerable Populations | 1 | 2019 | 163 | 0.140 |
Why?
|
| Diabetes Mellitus | 2 | 2011 | 532 | 0.130 |
Why?
|
| Telemedicine | 1 | 2011 | 215 | 0.130 |
Why?
|
| Obesity | 2 | 2013 | 1131 | 0.130 |
Why?
|
| Signal Transduction | 2 | 2013 | 2111 | 0.120 |
Why?
|
| Simvastatin | 1 | 2005 | 29 | 0.120 |
Why?
|
| Dyslipidemias | 1 | 2005 | 48 | 0.110 |
Why?
|
| Middle Aged | 9 | 2017 | 11819 | 0.110 |
Why?
|
| Nitric Oxide Synthase | 2 | 2005 | 134 | 0.110 |
Why?
|
| Georgia | 4 | 2019 | 189 | 0.090 |
Why?
|
| Humans | 13 | 2019 | 42163 | 0.090 |
Why?
|
| Adult | 7 | 2017 | 13458 | 0.090 |
Why?
|
| Risk Factors | 5 | 2017 | 3942 | 0.090 |
Why?
|
| Female | 9 | 2017 | 24018 | 0.080 |
Why?
|
| Community Networks | 2 | 2006 | 106 | 0.070 |
Why?
|
| Writing | 1 | 2018 | 41 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2011 | 1586 | 0.070 |
Why?
|
| Program Development | 1 | 2018 | 237 | 0.070 |
Why?
|
| Blood Pressure | 3 | 2006 | 662 | 0.070 |
Why?
|
| Education | 1 | 2017 | 60 | 0.060 |
Why?
|
| Societies, Medical | 1 | 2006 | 74 | 0.060 |
Why?
|
| Prejudice | 1 | 2017 | 116 | 0.060 |
Why?
|
| Male | 7 | 2017 | 22779 | 0.060 |
Why?
|
| Endothelium, Vascular | 2 | 2005 | 261 | 0.060 |
Why?
|
| Smoking | 2 | 2017 | 1019 | 0.060 |
Why?
|
| Group Practice | 1 | 2005 | 8 | 0.060 |
Why?
|
| Social Class | 1 | 2017 | 286 | 0.060 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2005 | 45 | 0.060 |
Why?
|
| Primary Health Care | 2 | 2005 | 362 | 0.060 |
Why?
|
| Insurance Coverage | 1 | 2005 | 108 | 0.050 |
Why?
|
| Community Health Services | 1 | 2005 | 207 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2017 | 916 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 1221 | 0.050 |
Why?
|
| Metabolomics | 1 | 2013 | 90 | 0.050 |
Why?
|
| Cooperative Behavior | 1 | 2005 | 250 | 0.050 |
Why?
|
| Schools, Medical | 1 | 2005 | 208 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2013 | 206 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2017 | 1729 | 0.050 |
Why?
|
| Comorbidity | 1 | 2005 | 725 | 0.050 |
Why?
|
| Receptors, CXCR3 | 1 | 2012 | 31 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2005 | 309 | 0.050 |
Why?
|
| Inflammation | 1 | 2017 | 729 | 0.050 |
Why?
|
| Aged | 4 | 2011 | 7982 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2004 | 381 | 0.040 |
Why?
|
| Genomics | 1 | 2013 | 289 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2013 | 421 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2017 | 641 | 0.040 |
Why?
|
| Consumer Health Information | 1 | 2011 | 24 | 0.040 |
Why?
|
| Health Promotion | 1 | 2006 | 691 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2017 | 705 | 0.040 |
Why?
|
| Algorithms | 1 | 2013 | 508 | 0.040 |
Why?
|
| Depression | 1 | 2017 | 837 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2005 | 680 | 0.040 |
Why?
|
| Lactation | 1 | 2008 | 44 | 0.040 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2008 | 26 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2011 | 733 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 1051 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2012 | 1617 | 0.030 |
Why?
|
| Social Support | 1 | 2011 | 438 | 0.030 |
Why?
|
| United States | 1 | 2017 | 5072 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2005 | 36 | 0.030 |
Why?
|
| Internal Medicine | 1 | 2005 | 32 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2005 | 73 | 0.030 |
Why?
|
| Age Factors | 1 | 2008 | 1139 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 1574 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2005 | 81 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2005 | 74 | 0.030 |
Why?
|
| Adolescent | 2 | 2012 | 5950 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2005 | 141 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2005 | 164 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2005 | 234 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2005 | 164 | 0.030 |
Why?
|
| Curriculum | 1 | 2005 | 311 | 0.020 |
Why?
|
| Pregnancy | 1 | 2008 | 1737 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 2803 | 0.020 |
Why?
|
| Young Adult | 1 | 2012 | 4936 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2005 | 727 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2005 | 585 | 0.020 |
Why?
|
| Diet | 1 | 2005 | 810 | 0.020 |
Why?
|
| South Carolina | 1 | 2006 | 25 | 0.020 |
Why?
|
| North Carolina | 1 | 2006 | 122 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2006 | 56 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 2005 | 29 | 0.010 |
Why?
|
| Systole | 1 | 2004 | 67 | 0.010 |
Why?
|
| Diastole | 1 | 2004 | 47 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2004 | 88 | 0.010 |
Why?
|
| Vasodilation | 1 | 2004 | 64 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2004 | 123 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2004 | 203 | 0.010 |
Why?
|
| Alleles | 1 | 2005 | 352 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2005 | 158 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2005 | 225 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 454 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 200 | 0.010 |
Why?
|
| Genotype | 1 | 2004 | 796 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2005 | 860 | 0.010 |
Why?
|
| Minority Groups | 1 | 2005 | 663 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2004 | 729 | 0.010 |
Why?
|